Cann Group

Established in 2014, Cann Group is the first company to be issued with a Cannabis Research Licence and Medicinal Cannabis Licence by the Australian Government's Office of Drug Control (ODC), and was subsequently issued with a Manufacture Licence by the ODC. These Licences authorize Cann Group to cultivate, produce and manufacture medicinal cannabis... (in association with a relevant permit) for therapeutic and research purposes. Cann Group's Board and management have extensive experience in the agriculture, agronomic and health research sectors and in developing and commercializing agricultural technology. Cann Group has established R&D and cultivation facilities in Australia and is pursuing a fully-integrated business model with collaboration agreements, resources and capabilities that will enable it to establish a leading position in plant genetics, breeding, cultivation, production, manufacturing, and clinical evaluation to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions. Cann Group's vision is to be a leading developer and supplier of cannabis, cannabis resin and medicinal cannabis products.Read More